Human Metabolome Technologies, Inc. (6090.T)

JPY 679.0

(-1.88%)

Gross Profit Summary of Human Metabolome Technologies, Inc.

  • Human Metabolome Technologies, Inc.'s latest annual gross profit in 2023 was 869.33 Million JPY , up 1.11% from previous year.
  • Human Metabolome Technologies, Inc.'s latest quarterly gross profit in 2023 FY was 869.33 Million JPY , up 1.11% from previous quarter.
  • Human Metabolome Technologies, Inc. reported a annual gross profit of 859.75 Million JPY in annual gross profit 2022, up 2.35% from previous year.
  • Human Metabolome Technologies, Inc. reported a annual gross profit of 840 Million JPY in annual gross profit 2021, up 4.22% from previous year.
  • Human Metabolome Technologies, Inc. reported a quarterly gross profit of 869.33 Million JPY for 2023 FY, up 1.11% from previous quarter.
  • Human Metabolome Technologies, Inc. reported a quarterly gross profit of 122.14 Million JPY for 2023 Q1, down -2.54% from previous quarter.

Annual Gross Profit Chart of Human Metabolome Technologies, Inc. (2023 - 2019)

Historical Annual Gross Profit of Human Metabolome Technologies, Inc. (2023 - 2019)

Year Gross Profit Gross Profit Growth
2023 869.33 Million JPY 1.11%
2022 859.75 Million JPY 2.35%
2021 840 Million JPY 4.22%
2020 806.01 Million JPY -5.92%
2019 856.72 Million JPY 0.0%

Peer Gross Profit Comparison of Human Metabolome Technologies, Inc.

Name Gross Profit Gross Profit Difference
Shin Nippon Biomedical Laboratories, Ltd. 14.28 Billion JPY 93.913%
DNA Chip Research Inc. 66.35 Million JPY -1210.162%
Cosmo Bio Company,Limited 3.25 Billion JPY 73.251%
H.U. Group Holdings, Inc. 63.23 Billion JPY 98.625%
FALCO HOLDINGS Co., Ltd. 12.71 Billion JPY 93.163%
BML, Inc. 45.62 Billion JPY 98.095%
Precision System Science Co., Ltd. 950.37 Million JPY 8.528%